tiprankstipranks
Trending News
More News >
Maravai Lifesciences Holdings (MRVI)
NASDAQ:MRVI
Advertisement

Maravai Lifesciences Holdings (MRVI) Stock Statistics & Valuation Metrics

Compare
400 Followers

Total Valuation

Maravai Lifesciences Holdings has a market cap or net worth of $617.98M. The enterprise value is $650.90M.
Market Cap$617.98M
Enterprise Value$650.90M

Share Statistics

Maravai Lifesciences Holdings has 144,677,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding144,677,780
Owned by Insiders
Owned by Institutions

Financial Efficiency

Maravai Lifesciences Holdings’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -24.24%.
Return on Equity (ROE)-0.45
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-24.24%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee454.71K
Profits Per Employee-455.48K
Employee Count570
Asset Turnover0.26
Inventory Turnover3.01

Valuation Ratios

The current PE Ratio of Maravai Lifesciences Holdings is ―. Maravai Lifesciences Holdings’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value2.31
Price to FCF
Price to Operating Cash Flow-17.99
PEG Ratio

Income Statement

In the last 12 months, Maravai Lifesciences Holdings had revenue of 259.19M and earned -144.85M in profits. Earnings per share was -1.05.
Revenue259.19M
Gross Profit108.31M
Operating Income-235.62M
Pretax Income-261.48M
Net Income-144.85M
EBITDA-156.92M
Earnings Per Share (EPS)-1.05

Cash Flow

In the last 12 months, operating cash flow was -21.16M and capital expenditures -23.05M, giving a free cash flow of -44.21M billion.
Operating Cash Flow-21.16M
Free Cash Flow-44.21M
Free Cash Flow per Share-0.31

Dividends & Yields

Maravai Lifesciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.75
52-Week Price Change-74.56%
50-Day Moving Average2.45
200-Day Moving Average3.39
Relative Strength Index (RSI)49.12
Average Volume (3m)1.54M

Important Dates

Maravai Lifesciences Holdings upcoming earnings date is Nov 5, 2025, After Close (Confirmed).
Last Earnings DateAug 11, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend Date

Financial Position

Maravai Lifesciences Holdings as a current ratio of 7.53, with Debt / Equity ratio of 13.90%
Current Ratio7.53
Quick Ratio6.65
Debt to Market Cap0.21
Net Debt to EBITDA-0.35
Interest Coverage Ratio-4.94

Taxes

In the past 12 months, Maravai Lifesciences Holdings has paid -1.86M in taxes.
Income Tax-1.86M
Effective Tax Rate<0.01

Enterprise Valuation

Maravai Lifesciences Holdings EV to EBITDA ratio is -9.46, with an EV/FCF ratio of -66.92.
EV to Sales5.73
EV to EBITDA-9.46
EV to Free Cash Flow-66.92
EV to Operating Cash Flow198.94

Balance Sheet

Maravai Lifesciences Holdings has $269.91M in cash and marketable securities with $371.08M in debt, giving a net cash position of $101.17M billion.
Cash & Marketable Securities$269.91M
Total Debt$371.08M
Net Cash$101.17M
Net Cash Per Share$0.70
Tangible Book Value Per Share$1.61

Margins

Gross margin is 29.11%, with operating margin of -90.91%, and net profit margin of -55.89%.
Gross Margin29.11%
Operating Margin-90.91%
Pretax Margin-100.89%
Net Profit Margin-55.89%
EBITDA Margin-60.54%
EBIT Margin-82.48%

Analyst Forecast

The average price target for Maravai Lifesciences Holdings is $4.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.67
Price Target Upside92.98% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast-22.52%
EPS Growth Forecast-37.00%

Scores

Smart Score6
AI Score44
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis